Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene

Cited by (831)

Items 101–200 of 831

  1. An Absolute Risk Model to Identify Individuals at Elevated Risk for Pancreatic Cancer in the General Population
    Klein, Alison P., Lindström, Sara, Mendelsohn, Julie B., Steplowski, Emily, Arslan, Alan A., Bueno-de-Mesquita, H. Bas, Fuchs, Charles S., Gallinger, Steven, Gross, Myron, Helzlsouer, Kathy et al. · 2013 · PLoS ONE
  2. Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinoma
    Nemanja Rodić, Jared P. Steranka, Alvin P. Makohon-Moore, Allison F. Moyer, Peilin Shen, Reema Sharma, Zachary A. Kohutek, Cheng Ran Lisa Huang, Daniel H. Ahn, Paolo Mita et al. · 2015 · Nature Medicine
  3. Molecular Signatures of Pancreatic Cancer
    Seung‐Mo Hong, Jason Y. Park, Ralph H. Hruban, Michael Goggins · 2011 · Archives of Pathology & Laboratory Medicine
  4. Cancer Genomics and Inherited Risk
    Zsofia Kinga Stadler, Kasmintan A. Schrader, Joseph Vijai, Mark E. Robson, Kenneth Offit · 2014 · Journal of Clinical Oncology
  5. Genome-Wide Association Study of Pancreatic Cancer in Japanese Population
    Siew‐Kee Low, Aya Kuchiba, Hitoshi Zembutsu, Akira Saito, Atsushi Takahashi, Michiaki Kubo, Yataro Daigo, Naoyuki Kamatani, Suenori Chiku, Hirohiko Totsuka et al. · 2010 · PLoS ONE
  6. Molecular Diagnostics in Clinical Oncology
    Анна Петровна Соколенко, Евгений Наумович Имянитов · 2018 · Frontiers in Molecular Biosciences
  7. Diabetes and Pancreatic Cancer: Chicken or Egg?
    Magruder, J. Trent, Elahi, Dariush, Andersen, Dana K. · 2011 · Pancreas
  8. RAD51C is a susceptibility gene for ovarian cancer
    Liisa M. Pelttari, Tuomas Heikkinen, Deborah J. Thompson, Anne H. Kallioniemi, Johanna Schleutker, Kaija Holli, CARL P. BLOMQVIST, Kristiina Aittomäki, Ralf C. Bützow, Heli A. Nevanlinna · 2011 · Human Molecular Genetics
  9. Demographics, Epidemiology, and Inheritance of Pancreatic Ductal Adenocarcinoma
    Theresa Pluth Yeo · 2014 · Seminars in Oncology
  10. Identifying people at a high risk of developing pancreatic cancer
    Alison P. Klein · 2012 · Nature reviews. Cancer
  11. Metabolism addiction in pancreatic cancer
    Roy Blum, Yoel Kloog · 2014 · Cell Death and Disease
  12. Autophagy Opposes p53-Mediated Tumor Barrier to Facilitate Tumorigenesis in a Model of PALB2 -Associated Hereditary Breast Cancer
    Yanying Huo, Hong Cai, Irina Teplova, Christian Bowman-Colin, Guanghua Chen, Sandy M. Price, Nicola Barnard, Shridar Ganesan, Vassiliki Karantza, Eileen White et al. · 2013 · Cancer Discovery
  13. Intraductal papillary mucinous neoplasm
    Chanjuan Shi, Ralph H. Hruban · 2011 · Human Pathology
  14. Pancreatitis-Diabetes-Pancreatic Cancer
    Dana K. Andersen, Åke Andrén‐Sandberg, Eric J. Duell, Michael Goggins, Murray Korc, Gloria M. Petersen, Jill Palmer Smith, David Clement Whitcomb · 2013 · Pancreas
  15. Identifying breast cancer susceptibility genes – a review of the genetic background in familial breast cancer
    Camilla Wendt, Sara Margolin · 2019 · Acta Oncologica
  16. Pancreatic Ductal Adenocarcinoma: Epidemiology and Risk Factors
    Jun Ushio, Atsushi Kanno, Eriko Ikeda, Kozue Ando, Hiroki Nagai, Tetsurou Miwata, Yuki Kawasaki, Yamato Tada, Kensuke Yokoyama, N. Numao et al. · 2021 · Diagnostics
  17. Surgical and molecular pathology of pancreatic neoplasms
    Wenzel M. Hackeng, Ralph H. Hruban, G. Johan A. Offerhaus, Lodewijk A.A. Brosens · 2016 · Diagnostic Pathology
  18. German national case collection for familial pancreatic cancer (FaPaCa): ten years experience
    Schneider, Ralph, Slater, Emily P., Sina, Mercede, Habbe, Nils, Fendrich, Volker, Matthäi, Elvira, Langer, Peter, Bartsch, Detlef K. · 2011 · Familial Cancer
  19. Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?
    Davide Angeli, Samanta Salvi, Gianluca Tedaldi · 2020 · International Journal of Molecular Sciences
  20. Inherited pancreatic cancer syndromes
    Solomon, Sheila, Das, Siddhartha, Brand, Randall, Whitcomb, David C. · 2012 · The Cancer Journal
  21. A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review
    Evan L. Fogel, Safi Shahda, Kumaresan Sandrasegaran, John M. DeWitt, Jeffrey J. Easler, David M. Agarwal, Mackenzie A. Eagleson, Nicholas Joseph Zyromski, Michael Garrett House, Susannah G. Ellsworth et al. · 2017 · The American Journal of Gastroenterology
  22. Identifying druggable disease-modifying gene products
    Scott J. Dixon, Brent R. Stockwell · 2009 · Current Opinion in Chemical Biology
  23. The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma
    Nardin Samuel, Thomas J. Hudson · 2011 · Nature Reviews Gastroenterology & Hepatology
  24. Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms
    Zeinab Safarpour Lima, Mostafa Ghadamzadeh, Farzad Tahmasebi Arashloo, Ghazaleh Amjad, Mohammad Reza Ebadi, Ladan Younesi · 2019 · Journal of Hematology & Oncology
  25. A novel germline PALB2 deletion in Polish breast and ovarian cancer patients
    Agnieszka Dansonka‐Mieszkowska, Anna Kluska, Joanna Moes-Sosnowska, Michalina Dąbrowska, Dorota Nowakowska, Anna Niwińska, Paweł Derlatka, Krzysztof Cendrowski, Jolanta Kupryjańczyk · 2010 · BMC Medical Genetics
  26. Links between genome integrity and BRCA1 tumor suppression
    Mischa Li Covington, Roger A. Greenberg · 2012 · Trends in Biochemical Sciences
  27. Gene panel sequencing in familial breast/ovarian cancer patients identifies multiple novel mutations also in genes others than BRCA1/2
    Cornelia S. Kraus, Juliane Hoyer, Georgia Vasileiou, Marius Wunderle, Michael Patrick Lux, Peter Andreas Fasching, Mandy Krumbiegel, Steffen Uebe, Miriam S. Reuter, Matthias W. Beckmann et al. · 2016 · International Journal of Cancer
  28. Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management
    Thomas Paul Slavin, Mariana Niell‐Swiller, Ilana B. Solomon, Bita Nehoray, Christina Rybak, Kathleen Reilly Blazer, Jeffrey N. Weitzel · 2015 · Frontiers in Oncology
  29. Biomarkers in Pancreatic Cancer
    Zhi Ven Fong, Jordan Michael Winter · 2012 · The Cancer Journal
  30. Targeting homologous recombination repair defects in cancer
    Bastiaan Evers, Thomas Helleday, Jos Jonkers · 2010 · Trends in Pharmacological Sciences
  31. Phosphorylated RPA recruits PALB2 to stalled DNA replication forks to facilitate fork recovery
    Anar Murphy, Michael Fitzgerald, Teresa Ro, Jee Hyun Kim, Ariana I. Rabinowitsch, Dipanjan Chowdhury, Carl L. Schildkraut, James A. Borowiec · 2014 · The Journal of Cell Biology
  32. DNA Double Strand Break Repair: A Radiation Perspective
    Joy N. Kavanagh, Kelly M. Redmond, Giuseppe Schettino, Kevin M. Prise · 2013 · Antioxidants and Redox Signaling
  33. The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms
    Saswati N. Chand, Kevin O’Hayer, Fernando F. Blanco, Jordan Michael Winter, Jonathan Robert Brody · 2016 · International Journal of Biological Sciences
  34. Familial pancreatic cancer: Concept, management and issues
    Hiroyuki Matsubayashi, Kyoichi Takaori, Chigusa Morizane, Hiroyuki Maguchi, Masamichi Mizuma, Hideaki Takahashi, Keita Wada, Hiroko Hosoi, Shinichi Yachida, Masami Suzuki et al. · 2017 · World Journal of Gastroenterology
  35. BRCA Mutations in Pancreas Cancer: Spectrum, Current Management, Challenges and Future Prospects
    Winston Wong, Alexander Grenander Raufi, Rachael Ann Safyan, Susan Elaine Bates, Gulam Abbas Manji · 2020 · Cancer Management and Research
  36. Hereditary Pancreatic Cancer
    Shilpa Grover, Sapna Syngal · 2010 · Gastroenterology
  37. Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine
    Erik S. Knudsen, Eileen Mary O'Reilly, Jonathan Robert Brody, Agnieszka Katarzyna Witkiewicz · 2015 · Gastroenterology
  38. The Role of PALB2 in the DNA Damage Response and Cancer Predisposition
    Thales C. Nepomuceno, Giuliana De Gregoriis, Francisco Meirelles Bastos de Oliveira, Guilherme Suarez‐Kurtz, Álvaro N.A. Monteiro, Marcelo Alex Carvalho · 2017 · International Journal of Molecular Sciences
  39. The Role of BRCA Testing in Hereditary Pancreatic and Prostate Cancer Families
    Robert Pilarski · 2019 · American Society of Clinical Oncology Educational Book
  40. State of the art and future directions of pancreatic ductal adenocarcinoma therapy
    Cindy Neuzillet, Annemilaï Tijeras‐Raballand, Philippe Bourget, Jerome F. Cros, Anne Couvelard, Alain Sauvanet, Marie‐Pierre Vullierme, Christophe Tournigand, Pascal R. Hammel · 2015 · Pharmacology & Therapeutics
  41. Very Long-term Survival Following Resection for Pancreatic Cancer Is Not Explained by Commonly Mutated Genes: Results of Whole-Exome Sequencing Analysis
    Dal Molin, Marco, Zhang, Ming, de Wilde, Roeland F., Ottenhof, Niki A., Rezaee, Neda, Wolfgang, Christopher L., Blackford, Amanda, Vogelstein, Bert, Kinzler, Kenneth W., Papadopoulos, Nickolas et al. · 2015 · Clinical Cancer Research
  42. Deleterious Germline Mutations Are a Risk Factor for Neoplastic Progression Among High-Risk Individuals Undergoing Pancreatic Surveillance
    Abe, Toshiya, Blackford, Amanda L., Tamura, Koji, Ford, Madeline, McCormick, Patrick, Chuidian, Miguel, Almario, Jose Alejandro, Borges, Michael, Lennon, Anne Marie, Shin, Eun Ji et al. · 2019 · Journal of Clinical Oncology
  43. Genetic predisposition to pancreatic cancer
    Paola Ghiorzo · 2014 · World Journal of Gastroenterology
  44. Familial pancreatic cancer: genetic advances
    Anil K. Rustgi · 2014 · Genes & Development
  45. Early Diagnosis of Pancreatic Cancer: The Key for Survival
    Gheorghe, Gina, Bungau, Simona, Ilie, Madalina, Behl, Tapan, Vesa, Cosmin Mihai, Brisc, Ciprian, Bacalbasa, Nicolae, Turi, Vladiana, Costache, Raluca Simona, Diaconu, Camelia Cristina · 2020 · Diagnostics
  46. Pancreatic Cancer Genetics
    Laufey Thora Amundadottir · 2016 · International Journal of Biological Sciences
  47. Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer
    Zsofia Kinga Stadler, Erin E. Salo‐Mullen, Sujata M. Patil, Maria Catherine Pietanza, Joseph Vijai, Emmanouil S. Saloustros, Nichole A. L. Hansen, Noah D. Kauff, Robert C. Kurtz, David Paul Kelsen et al. · 2011 · Cancer
  48. Genetic predisposition to colorectal cancer: Where we stand and future perspectives
    Laura Valle · 2014 · World Journal of Gastroenterology
  49. Molecular landscape of pancreatic cancer: implications for current clinical trials
    Gregory M. Heestand, Razelle Kurzrock · 2015 · Oncotarget
  50. Epigenetics and pancreatic cancer: Pathophysiology and novel treatment aspects
    Daniel Neureiter · 2014 · World Journal of Gastroenterology
  51. Risk of Pancreatic Cancer in Breast Cancer Families from the Breast Cancer Family Registry
    Evelina Mocci, Roger Laughlin Milne, Elena Yuste Méndez-Villamil, John Llewelyn Hopper, Esther M. John, Irene Louise Andrulis, Wendy K. Chung, Mary Beryl Daly, Saundra S. Buys, Núria Malats et al. · 2013 · Cancer Epidemiology Biomarkers & Prevention
  52. Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer
    Tamura, Koji, Yu, Jun, Hata, Tatsuo, Suenaga, Masaya, Shindo, Koji, Abe, Toshiya, MacGregor-Das, Anne, Borges, Michael, Wolfgang, Christopher L., Weiss, Matthew J. et al. · 2018 · Proceedings of the National Academy of Sciences
  53. Specific killing of DNA damage-response deficient cells with inhibitors of poly(ADP-ribose) glycohydrolase
    Polly Gravells, Emma K. Grant, Kate M. Smith, Dominic I. James, Helen E. Bryant · 2017 · DNA repair
  54. SLFN14 mutations underlie thrombocytopenia with excessive bleeding and platelet secretion defects
    Sarah J. Fletcher, Ben Johnson, Gillian Lowe, Danai Bem, Sian Drake, Marie Lordkipanidzé, Isabel Sánchez‐Guiu, Ban B. Dawood, José Rivera, Michael A. Simpson et al. · 2015 · Journal of Clinical Investigation
  55. Resolving gastric cancer aetiology: an update in genetic predisposition
    Paul C. Lott, Luis G. Carvajal‐Carmona · 2018 · The Lancet. Gastroenterology & hepatology
  56. Environmental risk factors for pancreatic cancer: an update
    Elisa Barone, Alda Corrado, Federica Gemignani, Stefano Landi · 2016 · Archives of Toxicology
  57. Current status of molecular markers for early detection of sporadic pancreatic cancer
    Subhankar Chakraborty, Michael J. Baine, Aaron R. Sasson, Surinder K. Batra · 2010 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  58. Molecular Mechanisms of PALB2 Function and Its Role in Breast Cancer Management
    Shijie Wu, Jiaojiao Zhou, Kun Zhang, Huihui Chen, Meng Luo, Yuexin Lu, Yuting Sun, Yiding Chen · 2020 · Frontiers in Oncology
  59. Genetics of familial and sporadic pancreatic cancer
    Wood, Laura D., Yurgelun, Matthew B., Goggins, Michael G. · 2019 · Gastroenterology
  60. Next-generation sequencing in cancer diagnosis and treatment: clinical applications and future directions
    Ghoreyshi, Nima, Heidari, Reza, Farhadi, Arezoo, Chamanara, Mohsen, Farahani, Nastaran, Vahidi, Mahmood, Behroozi, Javad · 2025 · Discover Oncology
  61. Treatment of Pancreatic Cancer Patient–Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin
    N.V. Rajeshkumar, Shinichi Yabuuchi, Shweta G. Pai, Elizabeth De Oliveira, Jurre J. Kamphorst, Joshua D. Rabinowitz, Héctor Tejero, Fátima Al‐Shahrour, Manuel M. Hidalgo, Anirban Maitra et al. · 2017 · Clinical Cancer Research
  62. Design of association studies with pooled or un‐pooled next‐generation sequencing data
    Su Yeon Kim, Yingrui Li, Yiran Guo, Ruiqiang Li, Johan Holmkvist, Torben F. Hansen, Oluf Borbye Pedersen, Jun Wang, Rasmus Nielsen · 2010 · Genetic Epidemiology
  63. Having Pancreatic Cancer with Tumoral Loss of ATM and Normal TP53 Protein Expression Is Associated with a Poorer Prognosis
    Haeryoung Kim, Burcu Saka, Spencer Knight, Michael W. Borges, Erica J. Childs, Alison P. Klein, Christopher Lee Wolfgang, Joseph M. Herman, Volkan N. Adsay, Ralph H. Hruban et al. · 2014 · Clinical Cancer Research
  64. Graphene-based nanopore approaches for DNA sequencing: A literature review
    Asma Wasfi, Falah R. Awwad, Ahmad I. Ayesh · 2018 · Biosensors and Bioelectronics
  65. Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphoma
    Silva Saarinen, Mervi Aavikko, Kristiina Aittomäki, Virpi Launonen, Rainer Lehtonen, Kaarle Franssila, Heli J. Lehtonen, Eevi Kaasinen, Peter Broderick, Jussi Tarkkanen et al. · 2011 · Blood
  66. Hereditary breast cancer: syndromes, tumour pathology and molecular testing
    Anna Sokolova, Kate J. Johnstone, Amy E. McCart Reed, Peter T. Simpson, Sunil R. Lakhani · 2022 · Histopathology
  67. Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive Glioblastoma
    Sara Ann Byron, Nhan L. Tran, Rebecca F. Halperin, Joanna J. Phillips, John G. Kuhn, John F. de Groot, Howard Colman, Keith Lloyd Ligon, Patrick Yung Wen, Timothy Francis Cloughesy et al. · 2017 · Clinical Cancer Research
  68. Demographics and Epidemiology of Pancreatic Cancer
    Theresa Pluth Yeo, Albert B. Lowenfels · 2012 · The Cancer Journal
  69. Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients
    Ella R. Thompson, Samantha E. Boyle, Julie Johnson, Georgina L. Ryland, Sarah Dilys Sawyer, David Y.H. Choong, kConFab, Georgia Chenevix‐Trench, Alison H. Trainer, Geoffrey John Lindeman et al. · 2011 · Human Mutation
  70. An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression
    Aamir Ali Khan, Xinhui Liu, Xinlong Yan, Muhammad Tahir, Sakhawat Ali, Hua Huang · 2021 · Cancer and Metastasis Reviews
  71. PALB2: The hub of a network of tumor suppressors involved in DNA damage responses
    Jung‐Young Park, Fan Zhang, Paul R. Andreassen · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  72. Hereditary cancer syndromes
    Евгений Наумович Имянитов, Ekatherina Sh. Kuligina, Анна Петровна Соколенко, Evgeny N. Suspitsin, Grigoriy A. Yanus, Aglaya G. Iyevleva, Alexandr O. Ivantsov, Светлана Николаевна Алексахина · 2023 · World Journal of Clinical Oncology
  73. Main dietary compounds and pancreatic cancer risk. The quantitative analysis of case–control and cohort studies
    Piotr Paluszkiewicz, Katarzyna Smolińska, Iwona Dębińska, Waldemar Andrzej Turski · 2011 · Cancer Epidemiology
  74. Increased Expression of DNA Repair Genes in Invasive Human Pancreatic Cancer Cells
    Lesley Mathews, Stephanie Cabarcas‐Petroski, Elaine M. Hurt, Xiaohu Zhang, Elizabeth M. Jaffee, William L. Farrar · 2011 · Pancreas
  75. Clinical Next Generation Sequencing for Precision Medicine in Cancer
    Ling Dong, Wanheng Wang, Alvin Li, Rina Kansal, Yuhan Chen, Hong Chen, Xinmin Li · 2015 · Current Genomics
  76. Olaparib in combination with irinotecan, cisplatin, and mitomycin C in patients with advanced pancreatic cancer
    Mark M. Yarchoan, Melinda C. Myzak, Burles Avner Johnson, Ana De Jesus‐Acosta, Dung Thi Le, Elizabeth M. Jaffee, Nilofer Saba Azad, Ross C. Donehower, Lei Zheng, Paul E. Oberstein et al. · 2017 · Oncotarget
  77. Initial testing (stage 1) of the PARP inhibitor BMN 673 by the pediatric preclinical testing program: PALB2 mutation predicts exceptional in vivo response to BMN 673
    Malcolm Anders Smith, Oliver A. Hampton, C. Patrick Reynolds, Min H. Kang, John M. Maris, Richard Greg Gorlick, Edward Anders Kolb, Richard B. Lock, Hernán Carol, Stephen Thomas Keir et al. · 2014 · Pediatric Blood & Cancer
  78. Pancreatic Cancer Screening
    Eun Ji Shin, Marcia Irene Canto · 2012 · Gastroenterology Clinics of North America
  79. Inactivation of Brca2 Promotes Trp53-Associated but Inhibits KrasG12D-Dependent Pancreatic Cancer Development in Mice
    Matthew Rowley, Akihiro Ohashi, Gourish Mondal, Lisa Mills, Lin Yang, Lizhi Zhang, Rhianna S. Sundsbak, Virginia Smith Shapiro, Michael H. Muders, Thomas C. Smyrk et al. · 2011 · Gastroenterology
  80. Germline mutations in Japanese familial pancreatic cancer patients
    Erina Takai, Shinichi Yachida, Kyoko Shimizu, Junji Furuse, Emi Kubo, Akihiro Ohmoto, Masami Suzuki, Ralph H. Hruban, Takuji Okusaka, Chigusa Morizane et al. · 2016 · Oncotarget
  81. Inherited Mutations in Breast Cancer Genes—Risk and Response
    Andrew Y. Shuen, William D. Foulkes · 2011 · Journal of Mammary Gland Biology and Neoplasia
  82. Diagnosis of digestive system tumours
    Mary Kay Washington, Richard M. Goldberg, George J. Chang, Paul J. Limburg, Alfred King-yin Lam, Manuel Salto‐Tellez, Mark Johan Arends, Irıs D. Nagtegaal, David S. Klimstra, Massimo Rugge et al. · 2020 · International Journal of Cancer
  83. Pancreatic adenocarcinoma pathology: changing "landscape".
    Lodewijk A.A. Brosens, Wenzel M. Hackeng, G. Johan A. Offerhaus, Ralph H. Hruban, Laura DeLong Wood · 2015 · Europe PMC (PubMed Central)
  84. Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward
    Mohammad Aslam Khan, Shafquat Azim, Haseeb Zubair, Arun Bhardwaj, Girijesh Kumar Patel, Moh'd M. Khushman, Seema Singh, Ajay P. Singh · 2017 · International Journal of Molecular Sciences
  85. Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications
    Andreia Brandão, Paula Paulo, Manuel Rodrigues Teixeira · 2020 · International Journal of Molecular Sciences
  86. CDKN2A is the main susceptibility gene in Italian pancreatic cancer families
    Paola Ghiorzo, Giuseppe Fornarini, Stefania Sciallero, Linda Battistuzzi, Fiorenza Belli, Loris Bernard, Luigina Ada Bonelli, Giacomo Borgonovo, William Bruno, Franco De Cian et al. · 2012 · Journal of Medical Genetics
  87. The Evolution of Cancer Risk Assessment in the Era of Next Generation Sequencing
    Heather Fecteau, Kristen J. Vogel, Kristen Hanson, Shannon M. Morrill‐Cornelius · 2014 · Journal of Genetic Counseling
  88. Type-3c Diabetes Mellitus, Diabetes of Exocrine Pancreas - An Update
    Subrat Kumar Bhattamisra, Tiew Chin Siang, Chieng Yi Rong, Naveenya Chetty Annan, Esther Ho Yung Sean, Lim Wen Xi, Ong Siu Lyn, Hui Shan Liew, Hira Choudhury, Manisha Pandey et al. · 2019 · Current Diabetes Reviews
  89. Fanconi anemia signaling network regulates the spindle assembly checkpoint
    Grzegorz Nalepa, Rikki Enzor, Zejin Sun, Christophe C. Marchal, Su-Jung Park, Yanzhu Yang, Laura Tedeschi, Stephanie L. Kelich, Helmut Hanenberg, D. Wade Clapp · 2013 · Journal of Clinical Investigation
  90. PALB2 (partner and localizer of BRCA2)
    Helmut Hanenberg, Paul R. Andreassen · 2018 · Atlas of Genetics and Cytogenetics in Oncology and Haematology
  91. High Prevalence of BRCA1 and BRCA2 Germline Mutations with Loss of Heterozygosity in a Series of Resected Pancreatic Adenocarcinoma and Other Neoplastic Lesions
    Aimee Lee Lucas, Reena Shakya, Marla D. Lipsyc, Elana B. Mitchel, Sheila Kumar, Caroline Hwang, Liyong Deng, Catherine DeVoe, John A. Chabot, Matthias J. Szabolcs et al. · 2013 · Clinical Cancer Research
  92. Genetics and Genetic Testing in Pancreatic Cancer
    David Clement Whitcomb, Celeste A. Shelton, Randall E. Brand · 2015 · Gastroenterology
  93. Epidemiology of pancreatic cancer and the role of family history
    Sara H. Olson, Robert C. Kurtz · 2012 · Journal of Surgical Oncology
  94. Rare genetic variants and the risk of cancer
    Walter Fred Bodmer, Ian P.M. Tomlinson · 2010 · Current Opinion in Genetics & Development
  95. Elevated Cancer Mortality in the Relatives of Patients with Pancreatic Cancer
    Li Wang, Kieran A. Brune, Kala Visvanathan, Daniel A. Laheru, Joseph M. Herman, C.L. Wolfgang, Richard David Schulick, John L. Cameron, Michael Goggins, Ralph H. Hruban et al. · 2009 · Cancer Epidemiology Biomarkers & Prevention
  96. ABO blood groups and pancreatic cancer risk and survival: Results from the PANcreatic Disease ReseArch (PANDoRA) consortium
    Cosmeri Rizzato, Daniele Campa, Raffaele Pezzilli, Pavel Souček, William Greenhalf, Gabriele Capurso, Renata Talar‐Wojnarowska, Anette Heller, Krzysztof Jamroziak, Kay‐Tee Khaw et al. · 2013 · Oncology Reports
  97. BRCA-mutant pancreatic ductal adenocarcinoma
    Eleonora Lai, Pina Ziranu, Dario Spanu, Marco Dubois, Andrea Pretta, Simona Tolu, Silvia Camera, Nicole Liscia, Stefano Mariani, Mara Persano et al. · 2021 · British Journal of Cancer
  98. Germline genetic variability in pancreatic cancer risk and prognosis
    Manuel Gentiluomo, Federico Canzian, Andrea Nicolini, Federica Gemignani, Stefano Landi, Daniele Campa · 2020 · Seminars in Cancer Biology
  99. Mutation in GNE is associated with severe congenital thrombocytopenia
    Jane Wong Fütterer, Amanda Dalby, Gillian Lowe, Ben Johnson, Michael A. Simpson, Jayashree Motwani, Mike Williams, Steve P. Watson, Neil V. Morgan · 2018 · Blood
  100. Identification of OSBPL2 as a novel candidate gene for progressive nonsyndromic hearing loss by whole-exome sequencing
    Guangqian Xing, Jun Yao, Bin Wu, Tingting Liu, Qinjun Wei, Cheng Liu, Yajie Lu, Zhibin Chen, Heng Zheng, Xiaonan Yang et al. · 2014 · Genetics in Medicine